Medical Marijuana I Stock EBITDA
| MJNA Stock | USD 0 0.0002 7.69% |
Medical Marijuana I fundamentals help investors to digest information that contributes to Medical Marijuana's financial success or failures. It also enables traders to predict the movement of Medical Pink Sheet. The fundamental analysis module provides a way to measure Medical Marijuana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Marijuana pink sheet.
Medical |
Medical Marijuana I Company EBITDA Analysis
Medical Marijuana's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Medical Marijuana EBITDA | 1.45 M |
Most of Medical Marijuana's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Marijuana I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Medical Marijuana I reported earnings before interest,tax, depreciation and amortization of 1.45 M. This is 99.83% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 99.96% higher than that of the company.
Medical EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Marijuana's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Marijuana could also be used in its relative valuation, which is a method of valuing Medical Marijuana by comparing valuation metrics of similar companies.Medical Marijuana is currently under evaluation in ebitda category among related companies.
Medical Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 62.53 M | |||
| Shares Outstanding | 3.44 B | |||
| Price To Earning | 5.25 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.86 X | |||
| Revenue | 58.98 M | |||
| Gross Profit | 57.73 M | |||
| EBITDA | 1.45 M | |||
| Net Income | 84.4 M | |||
| Cash And Equivalents | 4.68 M | |||
| Total Debt | 10.41 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 86.86 M | |||
| Earnings Per Share | 0 X | |||
| Number Of Employees | 91 | |||
| Beta | 1.12 | |||
| Market Capitalization | 56.49 M | |||
| Total Asset | 209.53 M | |||
| Retained Earnings | 31.14 M | |||
| Working Capital | 8.65 M | |||
| Current Asset | 14.02 M | |||
| Current Liabilities | 5.37 M | |||
| Z Score | 3.0 |
About Medical Marijuana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Marijuana I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Marijuana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Marijuana I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Marijuana I. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Medical Pink Sheet analysis
When running Medical Marijuana's price analysis, check to measure Medical Marijuana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Marijuana is operating at the current time. Most of Medical Marijuana's value examination focuses on studying past and present price action to predict the probability of Medical Marijuana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Marijuana's price. Additionally, you may evaluate how the addition of Medical Marijuana to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |